These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12358765)
1. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. Taylor DL; Diemel LT; Cuzner ML; Pocock JM J Neurochem; 2002 Sep; 82(5):1179-91. PubMed ID: 12358765 [TBL] [Abstract][Full Text] [Related]
2. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. Taylor DL; Diemel LT; Pocock JM J Neurosci; 2003 Mar; 23(6):2150-60. PubMed ID: 12657674 [TBL] [Abstract][Full Text] [Related]
3. Stimulation of microglial metabotropic glutamate receptor mGlu2 triggers tumor necrosis factor alpha-induced neurotoxicity in concert with microglial-derived Fas ligand. Taylor DL; Jones F; Kubota ES; Pocock JM J Neurosci; 2005 Mar; 25(11):2952-64. PubMed ID: 15772355 [TBL] [Abstract][Full Text] [Related]
4. Apoptotic pathways mobilized in microglia and neurones as a consequence of chromogranin A-induced microglial activation. Kingham PJ; Cuzner ML; Pocock JM J Neurochem; 1999 Aug; 73(2):538-47. PubMed ID: 10428049 [TBL] [Abstract][Full Text] [Related]
5. Targeting group II metabotropic glutamate (mGlu) receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies beta-amyloid toxicity in cultured neurons, whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective. Caraci F; Molinaro G; Battaglia G; Giuffrida ML; Riozzi B; Traficante A; Bruno V; Cannella M; Merlo S; Wang X; Heinz BA; Nisenbaum ES; Britton TC; Drago F; Sortino MA; Copani A; Nicoletti F Mol Pharmacol; 2011 Mar; 79(3):618-26. PubMed ID: 21159998 [TBL] [Abstract][Full Text] [Related]
6. Amyloid-beta neurotoxicity and clearance are both regulated by glial group II metabotropic glutamate receptors. Durand D; Carniglia L; Turati J; Ramírez D; Saba J; Caruso C; Lasaga M Neuropharmacology; 2017 Sep; 123():274-286. PubMed ID: 28495373 [TBL] [Abstract][Full Text] [Related]
7. Inhibiting p53 pathways in microglia attenuates microglial-evoked neurotoxicity following exposure to Alzheimer peptides. Davenport CM; Sevastou IG; Hooper C; Pocock JM J Neurochem; 2010 Jan; 112(2):552-63. PubMed ID: 19895660 [TBL] [Abstract][Full Text] [Related]
8. System Xc- and apolipoprotein E expressed by microglia have opposite effects on the neurotoxicity of amyloid-beta peptide 1-40. Qin S; Colin C; Hinners I; Gervais A; Cheret C; Mallat M J Neurosci; 2006 Mar; 26(12):3345-56. PubMed ID: 16554485 [TBL] [Abstract][Full Text] [Related]
9. Microglial apoptosis induced by chromogranin A is mediated by mitochondrial depolarisation and the permeability transition but not by cytochrome c release. Kingham PJ; Pocock JM J Neurochem; 2000 Apr; 74(4):1452-62. PubMed ID: 10737601 [TBL] [Abstract][Full Text] [Related]
18. Activation of metabotropic glutamate receptor 5 modulates microglial reactivity and neurotoxicity by inhibiting NADPH oxidase. Loane DJ; Stoica BA; Pajoohesh-Ganji A; Byrnes KR; Faden AI J Biol Chem; 2009 Jun; 284(23):15629-39. PubMed ID: 19364772 [TBL] [Abstract][Full Text] [Related]
19. Chromogranin A triggers a phenotypic transformation and the generation of nitric oxide in brain microglial cells. Taupenot L; Ciesielski-Treska J; Ulrich G; Chasserot-Golaz S; Aunis D; Bader MF Neuroscience; 1996 May; 72(2):377-89. PubMed ID: 8737408 [TBL] [Abstract][Full Text] [Related]
20. Identification of cathepsin B as a mediator of neuronal death induced by Abeta-activated microglial cells using a functional genomics approach. Gan L; Ye S; Chu A; Anton K; Yi S; Vincent VA; von Schack D; Chin D; Murray J; Lohr S; Patthy L; Gonzalez-Zulueta M; Nikolich K; Urfer R J Biol Chem; 2004 Feb; 279(7):5565-72. PubMed ID: 14612454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]